Phase 3 Readout~month

Phase 3 Topline: The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Af

Indication
Uveitis; Uveitis, Posterior; Uveitis, Anterior

Other upcoming events for ANIP

Patent ExpiryPatent/Exclusivity Expiry: BYVALSON
Patent ExpiryPatent/Exclusivity Expiry: OXTELLAR XR
Patent ExpiryPatent/Exclusivity Expiry: OPFOLDA
Patent ExpiryPatent/Exclusivity Expiry: LOREEV XR

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Af — ANIP Phase 3 Readout | BioSniper